Combination of a Compound Having the Ability to Rearrange a Lysosomal Enzyme and Ambroxol and/or a Derivative of Ambroxol
AssigneeCentogene IP GmbH
InventorsJan Lukas, Anahit Pews-Davtyan, Matthias Beller, Arndt Rolfs
Life of this patent
Estimating the term…
Abstract
The present invention is related to a combination comprising a first constituent and a second constituent, wherein the first constituent is a compound having the ability to rearrange a lysosomal protein, wherein the lysosomal protein has a reduced activity, and wherein the second constituent is Ambroxol and/or a derivative of Ambroxol.
Claims21
A method for the treatment of a subject suffering from a disease, wherein the method comprises administering a first constituent and a second constituent to the subject, wherein the first constituent is a compound having the ability to rearrange a lysosomal protein, wherein the lysosomal protein has a reduced activity and is selected from the group consisting of alpha-galactosidase A and alpha-glucosidase, and
- wherein the second constituent is Ambroxol and/or a derivative of Ambroxol.
-6. (canceled)
(canceled)
-290. (canceled)
Dependencies are inferred from the claim text.